10x Genomics (TXG) Accumulated Expenses (2018 - 2026)
10x Genomics' Accumulated Expenses history spans 8 years, with the latest figure at $42.5 million for Q4 2025.
- On a quarterly basis, Accumulated Expenses rose 26.43% to $42.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $42.5 million, a 26.43% increase, with the full-year FY2025 number at $42.5 million, up 26.43% from a year prior.
- Accumulated Expenses hit $42.5 million in Q4 2025 for 10x Genomics, up from $37.1 million in the prior quarter.
- Over the last five years, Accumulated Expenses for TXG hit a ceiling of $62.0 million in Q3 2022 and a floor of $17.6 million in Q1 2023.
- Historically, Accumulated Expenses has averaged $33.9 million across 5 years, with a median of $33.1 million in 2022.
- Biggest five-year swings in Accumulated Expenses: soared 142.94% in 2021 and later plummeted 54.06% in 2023.
- Tracing TXG's Accumulated Expenses over 5 years: stood at $50.9 million in 2021, then tumbled by 35.82% to $32.7 million in 2022, then fell by 7.87% to $30.1 million in 2023, then increased by 11.66% to $33.6 million in 2024, then increased by 26.43% to $42.5 million in 2025.
- Business Quant data shows Accumulated Expenses for TXG at $42.5 million in Q4 2025, $37.1 million in Q3 2025, and $26.1 million in Q2 2025.